CochlearCHEOF 62 Days Inventory is 301.71 as of Dec. 2025, which is 47% above its 10-year median of 205.83. GuruFocus rates CHEOF with a GF Score™ of 62/100 and a GF Value™ of $210.35 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Cochlear ranks worse than 76.21% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Cochlear's Average Total Inventories for the
six
months ended in Dec. 2025 was $351 Mil. Cochlear's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $212 Mil.
Hence, Cochlear's Days Inventory for the
six
months ended in Dec. 2025 was 301.71.
The historical rank and industry rank for Cochlear's Days Inventory or its related term are showing as below:
CHEOF'
s Days Inventory Range Over the Past 10 Years
Min: 159.96 Med: 205.83 Max: 291.63
Current: 291.63
During the past 13 years, Cochlear's highest Days Inventory was 291.63. The lowest was 159.96. And the median was 205.83.
CHEOF's Days Inventory is ranked worse than 76.21% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.785
vs CHEOF: 291.63
Cochlear's Days Inventory
increased
from Dec. 2024 (267.37) to Dec. 2025 (301.71).
It might indicate that Cochlear's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Cochlear's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.60.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cochlear's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.45.
Cochlear (OTCPK:CHEOF) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Cochlear's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Cochlear's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Cochlear Days Inventory Related Terms
Cochlear Days Inventory Historical Data
* Premium members only.
The historical data trend for Cochlear's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Cochlear's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cochlear Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cochlear's Days Inventory distribution charts can be found below:
* The bar in red indicates where Cochlear's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cochlear (CHEOF) has a Days Inventory of 301.71 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cochlear and its competitors. This is 47% above median its historical median of 205.83. Over the past decade, Cochlear's Days Inventory has ranged from 159.96 to 291.63. According to the industry distribution chart, Cochlear ranks #599 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 76.2%.
Is Cochlear's Days Inventory too high?
Cochlear's current Days Inventory of 301.71 is 47% above median its 10-year median of 205.83. Over the past 10 years, this metric has ranged from a low of 159.96 to a high of 291.63. The Medical Devices & Instruments industry median Days Inventory is 179.79. Cochlear's value of 301.71 is 67.8% above this industry median. Based on the distribution chart, Cochlear ranks #599 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Cochlear has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Cochlear's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Cochlear ranks #599 out of 786 companies for Days Inventory. This places Cochlear in the lower half of its industry. The industry median Days Inventory is 179.79. Cochlear's value of 301.71 is 67.8% above this benchmark. Historically, Cochlear's own Days Inventory has ranged from 159.96 to 291.63 over the past decade. While the company's 10-year median is 205.83 vs. the industry median of 179.79, Cochlear has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.79, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cochlear's current Days Inventory of 301.71 is 67.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Cochlear and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.79 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cochlear's current Days Inventory is 301.71, which is 47% above median its own 10-year median of 205.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cochlear stock overvalued right now?
Based on GuruFocus' analysis, Cochlear (CHEOF) is currently considered Significantly Undervalued. The stock's GF Value™ is $210.35, compared to a current price of $81.42 — trading 61.3% below its estimated fair value. The current Days Inventory is 301.71, which is 47% above median its 10-year median of 205.83 and 67.8% above the Medical Devices & Instruments industry median of 179.79. Cochlear's overall GF Score™ is 62/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Cochlear (CHEOF), the current Days Inventory is 301.71 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cochlear (CHEOF) Overvalued in 2026?
Based on GuruFocus' analysis, Cochlear stock appears to be undervalued.
The current stock price of $81.42 is trading 61.3% below its estimated GF Value™ of $210.35.
GuruFocus considers Cochlear to be Significantly Undervalued.
Key valuation signals for CHEOF:
Days Inventory: 301.71 (47% above median its 10-year median of 205.83)
GF Value™: $210.35 vs. price of $81.42 (61.3% below fair value)
Industry Position: 67.8% above the Medical Devices & Instruments median (#599 of 786)
No single metric tells the full story. See the CHEOF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cochlear is the leading cochlear implant device manufacturer, with around 60% global market share. Developed markets contribute 80% of group revenue, where cochlear implants are the standard of care for children with severe-to-profound hearing loss. The company also actively targets the growing cohort of seniors in developed markets. Tender-oriented emerging markets contribute the remaining 20% of group revenue. Main products include cochlear implants, bone-anchored hearing aids, and associated sound processors. In fiscal 2025, 49% of revenue came from the Americas, 34% from Europe, the Middle East, and Africa, and 18% from the Asia-Pacific segment.
62GF Score
Get the complete analysis for CHEOF
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHEOF has been successfully added to your 
